NCT00672984View on ClinicalTrials.gov

Guanfacine Immediate-release Electrocardiogram Results (QTc) Study

PHASE1CompletedINTERVENTIONAL
Enrollment

83

Participants

Timeline

Start Date

April 18, 2008

Primary Completion Date

August 7, 2008

Study Completion Date

August 7, 2008

Conditions
Healthy Volunteers
Interventions
DRUG

immediate release guanfacine hydrochloride

Subjects will receive 2x2mg immediate-release guanfacine on day 1. Subjects will receive 4x2mg immediate-release guanfacine on day 6.

DRUG

moxifloxacin

Subjects will receive 400mg of moxifloxacin on day 1. Subjects will receive 400mg of moxifloxacin on day 6.

DRUG

Placebo

Subjects will receive placebo on Day 1. Subjects will receive placebo on Day 6.

Trial Locations (1)

Unknown

Charles River Clinical Services Northwest, Inc., Tacoma

Sponsors

Lead Sponsor

Shire
All Listed Sponsors
lead

Shire

INDUSTRY

NCT00672984 - Guanfacine Immediate-release Electrocardiogram Results (QTc) Study | Biotech Hunter | Biotech Hunter